Literature DB >> 10842325

B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta.

M N Weitzmann1, S Cenci, J Haug, C Brown, J DiPersio, R Pacifici.   

Abstract

The role of B lymphocytes in osteoclast (OC) formation is controversial, because both stimulatory and inhibitory effects of B-lineage cells on osteoclastogenesis and life span have been reported. In this study, we have investigated the effects of mature B cells on human osteoclastogenesis using cultures of peripheral blood stem cells (PBSC), a system that generates functional OCs in the absence of stromal cells. We report that B cells inhibit the formation of OCs and shorten the life span of mature OCs by secreting transforming growth factor beta (TGFbeta), a factor that induces apoptosis in these cells. The antiosteoclastogenic effects of B cells are abolished by addition of anti-TGFbeta antibody to osteoclast cultures and mimicked by treatment of B cell-deprived PBSC cultures with recombinant TGFbeta, thus confirming TGFbeta as the B cell produced antiosteoclastogenic activity. Thus, the ability of B cells to downregulate osteoclastogenesis by secretion of the apoptotic cytokine TGFbeta provides new insights into the ability of immune cells to regulate OC formation under basal and inflammatory conditions. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842325     DOI: 10.1002/(sici)1097-4644(20000801)78:2<318::aid-jcb13>3.0.co;2-n

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

1.  RANK ligand and the regulation of skeletal remodeling.

Authors:  Norman H Bell
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 2.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

3.  B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.

Authors:  Yan Li; Gianluca Toraldo; Aimin Li; Xiaoying Yang; Hongying Zhang; Wei-Ping Qian; M Neale Weitzmann
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 4.  Inflammation, mesenchymal stem cells and bone regeneration.

Authors:  Hongrui Liu; Dongfang Li; Yi Zhang; Minqi Li
Journal:  Histochem Cell Biol       Date:  2018-02-12       Impact factor: 4.304

Review 5.  Role of the immune system in postmenopausal bone loss.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  Curr Osteoporos Rep       Date:  2005-09       Impact factor: 5.096

6.  Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis.

Authors:  G Wheater; V E Hogan; Y K O Teng; J Tekstra; F P Lafeber; T W J Huizinga; J W J Bijlsma; R M Francis; S P Tuck; H K Datta; J M van Laar
Journal:  Osteoporos Int       Date:  2011-04-06       Impact factor: 4.507

Review 7.  HIV: inflammation and bone.

Authors:  Ighovwerha Ofotokun; Emily McIntosh; M Neale Weitzmann
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

8.  In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.

Authors:  Peng Xiao; Yuan Chen; Hui Jiang; Yao-Zhong Liu; Feng Pan; Tie-Lin Yang; Zi-Hui Tang; Jennifer A Larsen; Joan M Lappe; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

9.  Immunology of Gut-Bone Signaling.

Authors:  Fraser L Collins; Jonathan D Schepper; Naiomy Deliz Rios-Arce; Michael D Steury; Ho Jun Kang; Heather Mallin; Daniel Schoenherr; Glen Camfield; Saima Chishti; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 10.  Trauma-induced heterotopic bone formation and the role of the immune system: A review.

Authors:  Casey T Kraft; Shailesh Agarwal; Kavitha Ranganathan; Victor W Wong; Shawn Loder; John Li; Matthew J Delano; Benjamin Levi
Journal:  J Trauma Acute Care Surg       Date:  2016-01       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.